Filtration Parameters Influencing Circulating Tumor Cell Enrichment from Whole Blood

被引:81
作者
Coumans, Frank A. W. [1 ]
van Dalum, Guus [1 ]
Beck, Markus [1 ]
Terstappen, Leon W. M. M. [1 ]
机构
[1] Univ Twente, MIRA Inst, NL-7500 AE Enschede, Netherlands
基金
欧洲研究理事会;
关键词
CANCER-PATIENTS; PERIPHERAL-BLOOD; BREAST-CANCER; HUMAN NEUTROPHILS; PROSTATE-CANCER; LUNG-CANCER; FLOW; SUSPENSIONS; SURVIVAL; ENUMERATION;
D O I
10.1371/journal.pone.0061774
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Filtration can achieve circulating tumor cell (CTC) enrichment from blood. Key parameters such as flow-rate, applied pressure, and fixation, vary largely between assays and their influence is not well understood. Here, we used a filtration system, to monitor these parameters and determine their relationships. Whole blood, or its components, with and without spiked tumor cells were filtered through track-etched filters. We characterize cells passing through filter pores by their apparent viscosity; the viscosity of a fluid that would pass with the same flow. We measured a ratio of 5 center dot 10(4):10(2):1 for the apparent viscosities of 15 mu m diameter MDA-231 cells, 10 mu m white cells and 90 fl red cells passing through a 5 mu m pore. Fixation increases the pressure needed to pass cells through 8 mu m pores 25-fold and halves the recovery of spiked tumor cells. Filtration should be performed on unfixed samples at a pressure of similar to 10 mbar for a 1 cm(2) track-etched filter with 5 mu m pores. At this pressure MDA-231 cells move through the filter in 1 hour. If fixation is needed for sample preservation, a gentle fixative should be selected. The difference in apparent viscosity between CTC and blood cells is key in optimizing recovery of CTC.
引用
收藏
页数:9
相关论文
共 56 条
[1]  
Adams D, 2011, ISOLATION CIRCULATIN
[2]   Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients [J].
Alix-Panabières, C ;
Rebillard, X ;
Brouillet, JP ;
Barbotte, E ;
Iborra, F ;
Segui, B ;
Maudelonde, T ;
Jolivet-Reynaud, C ;
Vendrell, JP .
CLINICAL CHEMISTRY, 2005, 51 (08) :1538-1541
[3]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[4]  
BAGGE U, 1977, ADV MICROCIRCULAT, V7, P18
[5]  
CHIEN S, 1983, BIORHEOLOGY, V20, P11
[6]   An electrical biosensor for the detection of circulating tumor cells [J].
Chung, Yao-Kuang ;
Reboud, Julien ;
Lee, Kok Chuan ;
Lim, Hui Min ;
Lim, Pei Yi ;
Wang, Karen Yanping ;
Tang, Kum Cheong ;
Ji, HongMiao ;
Chen, Yu .
BIOSENSORS & BIOELECTRONICS, 2011, 26 (05) :2520-2526
[7]   Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer [J].
Cohen, Steven J. ;
Punt, Cornelis J. A. ;
Iannotti, Nicholas ;
Saidman, Bruce H. ;
Sabbath, Kert D. ;
Gabrail, Nashat Y. ;
Picus, Joel ;
Morse, Michael ;
Mitchell, Edith ;
Miller, M. Craig ;
Doyle, Gerald V. ;
Tissing, Henk ;
Terstappen, Leon W. M. M. ;
Meropol, Neal J. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3213-3221
[8]  
Coumans FAW, 2013, METHODS MOL BIOL CIR
[9]  
Coumans FAW, 2013, PLOS ONE IN PRESS
[10]   Challenges in the Enumeration and Phenotyping of CTC [J].
Coumans, Frank A. W. ;
Ligthart, Sjoerd T. ;
Uhr, Jonathan W. ;
Terstappen, Leon W. M. M. .
CLINICAL CANCER RESEARCH, 2012, 18 (20) :5711-5718